Safety of anacetrapib in patients with or at high risk for coronary heart disease.
New England Journal of Medicine.
Times cited: 574
Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib.
American Heart Journal.
Times cited: 74
Intensive versus moderate lipid lowering with statins after acute coronary syndromes  (multiple letters).
American Journal of Clinical Nutrition.
Times cited: 1